Jiang Weiwen, executive Vice Minister of the Organization Department of Zhaoqing Municipal Party Committee, visited Chen Ruiai, chairman of the company

Recently, the Zhaoqing High-tech Zone Management Committee has awarded our company a plaque as "Enterprise with an Annual Output Value of Over 2 Billion Yuan in the Zhaoqing High-tech Zone for the Year 2022".

In 2022, Dahuanong overcame the continuous impact of the COVID-19 pandemic, extreme industry competition, and other pressures. Under the guidance and support of the group, it fully leveraged the sense of ownership, responsibility, and leadership of its cadres and employees. It harnessed the driving force of scientific and technological innovation, united the team's efforts, and achieved a "double harvest" in both technological innovation and business performance. The annual revenue exceeded 2.1 billion yuan, and it was awarded the first prize of the Guangdong Province Science and Technology Progress Award. It obtained 5 new veterinary drugs, including one exclusively developed Category I new veterinary drug, making a positive contribution to the local economic development.

Dahuanong will continue to take on the mission of "being an expert in animal health care and serving human health." It will strengthen confidence, forge ahead bravely, and continue to promote high-quality development. It will earnestly fulfill its social and economic responsibilities and make new and greater contributions to the local economic construction.